Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia A

Cristina Olgasi, Maria Talmon, Simone Merlin, Alessia Cucci, Yvonne Richaud-Patin, Gabriella Ranaldo, Donato Colangelo, Federica Di Scipio, Giovanni N. Berta, Chiara Borsotti, Federica Valeri, Francesco Faraldi, Maria Prat, Maria Messina, Piercarla Schinco, Angelo Lombardo, Angel Raya, Antonia Follenzi

Research output: Contribution to journalArticlepeer-review

Abstract

Follenzi and colleagues show that endothelial cells can be obtained starting from blood CD34+ cells of both healthy and hemophilic donors passing through iPSC generation. During the differentiation process the cells can be genetically modified by LV to express FVIII; corrected endothelial cells secrete FVIII in vitro and ameliorate the hemophilic phenotype in a mouse model of the disease.

Original languageEnglish
Pages (from-to)1391-1406
Number of pages16
JournalStem Cell Reports
Volume11
Issue number6
DOIs
Publication statusPublished - 11 Dec 2018

Keywords

  • FVIII
  • cell and gene therapy
  • chimeric vasculature
  • endothelial cells
  • hemophilia A
  • induced pluripotent stem cells (iPSCs)
  • lentiviral vectors

Fingerprint

Dive into the research topics of 'Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia A'. Together they form a unique fingerprint.

Cite this